In progress

Treatment of Breakthrough and Prevention of Refractory Chemotherapy-induced Nausea and Vomiting in Pediatric Cancer Patients: 2022 Clinical Practice Guideline Update

Expected Delivery Date
April 2023
Topic
Chemotherapy-induced nausea and vomiting
Type
Clinical Practice Guideline
Developing Organization:
POGO
Contact Name
Paula Robinson
Contact Email Address
[email protected]

Overview

Scope: Treatment of breakthrough and prevention of refractory chemotherapy-induced nausea and vomiting in pediatric patients with cancer.
Methods: An international and multidisciplinary panel used the GRADE approach to develop recommendations based on the results of systematic reviews of the literature.
 
 

Related Guidance

View All

Discover

View our guidance library

Explore guidance for providing optimal supportive care to children receiving cancer treatments or undergoing bone marrow transplant.

Learn More
Stay connected

Sign up to receive the iPOG Network quarterly newsletter!